AAAAAA

   
Results: 1-19 |
Results: 19
CLINICAL-EXPERIENCE WITH TEMPORARY VENA-CAVAL FILTERS
Authors: ZWAAN M LORCH H KULKE C KAGEL C SCHWIEDER G SIEMENS HJ MULLER G EBERHARDT I WAGNER T WEISS HD
Citation: M. Zwaan et al., CLINICAL-EXPERIENCE WITH TEMPORARY VENA-CAVAL FILTERS, Journal of vascular and interventional radiology, 9(4), 1998, pp. 594-601
FIBRINOLYSIS-ADJUSTED PERIOPERATIVE LOW-DOSE APROTININ REDUCES BLOOD-LOSS IN BYPASS OPERATIONS
Authors: MISFELD M DUBBERT S ELEFTHERIADIS S SIEMENS HJ WAGNER T SIEVERS HH
Citation: M. Misfeld et al., FIBRINOLYSIS-ADJUSTED PERIOPERATIVE LOW-DOSE APROTININ REDUCES BLOOD-LOSS IN BYPASS OPERATIONS, The Annals of thoracic surgery, 66(3), 1998, pp. 792-799
URINARY PROTHROMBINFRAGMENTS F1+2 AS EARLY DIAGNOSTIC MARKERS OF INTERSTITIAL REJECTION IN NTX PATIENTS
Authors: SIEMENS HJ BRUECKNER S STEINHOFF J WAGNER T SACK K
Citation: Hj. Siemens et al., URINARY PROTHROMBINFRAGMENTS F1+2 AS EARLY DIAGNOSTIC MARKERS OF INTERSTITIAL REJECTION IN NTX PATIENTS, Thrombosis and haemostasis, 1997, pp. 2488-2488
IN CONTRAST TO 5-PERCENT GLUCOSE SOLUTION MOLECULAR MARKERS OF HEMOSTASIS REVEAL A THROMBOPHILIC STATE AFTER SHORT-TIME VOLUME EXPANSION WITH RINGERS SOLUTION
Authors: SIEMENS HJ BRUECKNER S KIRMIZITAS C KLOTZ K WAGNER T SCHMUCKER P
Citation: Hj. Siemens et al., IN CONTRAST TO 5-PERCENT GLUCOSE SOLUTION MOLECULAR MARKERS OF HEMOSTASIS REVEAL A THROMBOPHILIC STATE AFTER SHORT-TIME VOLUME EXPANSION WITH RINGERS SOLUTION, Thrombosis and haemostasis, 1997, pp. 2495-2495
AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M RAMES A BASLE CH TENCATE JW SCHNEIDER PA GENEVA CH SCHMITT HE SLOSMAN DO PERRIER A SPANNAGL H GSCHWANDTNER ME BANYAI M KOPPENSTEINER R MINAR E STUMPFLEN A HAUMER M VERHAEGHE R VERMYLEN J WAUTRECHT JC TAGHIZADEH K BRUHN HD LINS M ZURBORN KH SCHWARZENBERG H SCHAUER J SCHEEL H RUHLMANN C VOIGT H WAGNER T SIEMENS HJ SCHWIEDER G HEENE D DEMPFLE CE HARENBERG J PFITZNER S BROCKHAUS W SCHUSTER O WEISSHAAR K SEBIGER R HOFMANN B ANDERS O KRAMMER B PLATH F LESTIN H BAUMANN N EHRERTREICH U MULLERESCH G RUPRECHT B WEDEEN G LARFARS G WALLVIK J BJUHR O DIDIER D DESMARAIS S WUTSCHERT R DEMOERLOOSE P CHRISTEN Y BERNARD C KUPKA S KIRISITS A JANSSEN M VERWEIJ G KRAAJ CJ SITTNER WD HANKA U MAIER A JOHANSSON AS JOHANSSON E OLESEN M BREIER E WITTKE B GOGGIN T STEPHENSON C TURKISH M WILLIAMS L DUTREIX C GAUTSCH A NONN D WARD R LOWE P LAD K GREEN D GRAVEL A
Citation: H. Bounameaux et al., AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 78(3), 1997, pp. 997-1002
BIGATED TRANSCRANIAL DOPPLER FOR THE DETECTION OF CLINICALLY SILENT CIRCULATING EMBOLI IN NORMAL PERSONS AND PATIENTS WITH PROSTHETIC CARDIAC VALVES
Authors: DROSTE DW HAGEDORN G NOTZOLD A SIEMENS HJ SIEVERS HH KAPS M
Citation: Dw. Droste et al., BIGATED TRANSCRANIAL DOPPLER FOR THE DETECTION OF CLINICALLY SILENT CIRCULATING EMBOLI IN NORMAL PERSONS AND PATIENTS WITH PROSTHETIC CARDIAC VALVES, Stroke, 28(3), 1997, pp. 588-592
MOLECULAR HEMOSTATIC MONITORING INCLUDING NEW FACTOR VIIA UNDER A MODIFIED APROTININ-REGIME VS TRANEXAMIC ACID IN CPBG
Authors: DUBBERT S MISFELD M SIEMENS HJ SIEVERS HH KUPPE H
Citation: S. Dubbert et al., MOLECULAR HEMOSTATIC MONITORING INCLUDING NEW FACTOR VIIA UNDER A MODIFIED APROTININ-REGIME VS TRANEXAMIC ACID IN CPBG, Anesthesiology, 87(3), 1997, pp. 977-977
FIRST CLINICAL-APPLICATION OF THE MEDOS-HIA VENTRICULAR SUPPORT SYSTEM - MONITORING OF THE THROMBOTIC RISK BY MEANS OF THE BIOMARKER PROTHROMBIN FRAGMENT F-1-MICROSCOPY EVALUATION(2 AND SCANNING ELECTRON)
Authors: GULDNER NW SIEMENS HJ SCHRAMM U KRAATZ E THUAUDET S KUPPE H SIEVERS HH
Citation: Nw. Guldner et al., FIRST CLINICAL-APPLICATION OF THE MEDOS-HIA VENTRICULAR SUPPORT SYSTEM - MONITORING OF THE THROMBOTIC RISK BY MEANS OF THE BIOMARKER PROTHROMBIN FRAGMENT F-1-MICROSCOPY EVALUATION(2 AND SCANNING ELECTRON), The Journal of heart and lung transplantation, 15(3), 1996, pp. 291-296
INFLUENCE OF INDUCTION OF HSP70 ON THE CYTOTOXICITY OF OXAZAPHOSPHORINE COMPOUNDS AND CISPLATIN
Authors: WOSSMANN W SIEMENS HJ BECK B JANSEN B WIEDEMANN GJ WAGNER T
Citation: W. Wossmann et al., INFLUENCE OF INDUCTION OF HSP70 ON THE CYTOTOXICITY OF OXAZAPHOSPHORINE COMPOUNDS AND CISPLATIN, International journal of oncology, 9(2), 1996, pp. 305-312
DETECTION OF A HYPERCOAGULABLE STATE IN NONVALVULAR ATRIAL-FIBRILLATION AND THE EFFECT OF ANTICOAGULANT-THERAPY
Authors: MITUSCH R SIEMENS HJ GARBE M WAGNER T SHEIKHZADEH A DIEDERICH KW
Citation: R. Mitusch et al., DETECTION OF A HYPERCOAGULABLE STATE IN NONVALVULAR ATRIAL-FIBRILLATION AND THE EFFECT OF ANTICOAGULANT-THERAPY, Thrombosis and haemostasis, 75(2), 1996, pp. 219-223
ASYMPTOMATIC CIRCULATING CEREBRAL EMBOLI AND CEREBRAL BLOOD-FLOW VELOCITY UNDER ASPIRIN AND TICLOPIDINE IN PATIENTS WITH CEREBROVASCULAR-DISEASE
Authors: DROSTE DW SONNE M SIEMENS HJ KAPS M
Citation: Dw. Droste et al., ASYMPTOMATIC CIRCULATING CEREBRAL EMBOLI AND CEREBRAL BLOOD-FLOW VELOCITY UNDER ASPIRIN AND TICLOPIDINE IN PATIENTS WITH CEREBROVASCULAR-DISEASE, Neurological research, 18(5), 1996, pp. 449-453
VARIABILITY IN OCCURRENCE OF EMBOLIC SIGNALS IN LONG-TERM TRANSCRANIAL DOPPLER RECORDINGS
Authors: DROSTE DW DECKER W SIEMENS HJ KAPS M SCHULTEALTEDORNEBURG G
Citation: Dw. Droste et al., VARIABILITY IN OCCURRENCE OF EMBOLIC SIGNALS IN LONG-TERM TRANSCRANIAL DOPPLER RECORDINGS, Neurological research, 18(1), 1996, pp. 25-30
HEMOSTASEOLOGIC AND HEMATOLOGIC PARAMETERS WITH ASPIRIN AND TICLOPIDINE TREATMENT IN PATIENTS WITH CEREBROVASCULAR-DISEASE - A CROSS-OVER STUDY
Authors: DROSTE DW SIEMENS HJ SONNE M KAPS M WAGNER T
Citation: Dw. Droste et al., HEMOSTASEOLOGIC AND HEMATOLOGIC PARAMETERS WITH ASPIRIN AND TICLOPIDINE TREATMENT IN PATIENTS WITH CEREBROVASCULAR-DISEASE - A CROSS-OVER STUDY, Journal of cardiovascular pharmacology, 28(4), 1996, pp. 591-594
DOES SHORT-TIME VOLUME EXPANSION PROVOKE A HYPERCOAGULABLE STATE - THIS THESIS IS SUPPORTED BY MOLECULAR MARKERS HEMOSTASIS
Authors: SIEMENS HJ BRUECKNER S KIRMICITAS C KLOTZ K WAGNER T SCHMUCKER P
Citation: Hj. Siemens et al., DOES SHORT-TIME VOLUME EXPANSION PROVOKE A HYPERCOAGULABLE STATE - THIS THESIS IS SUPPORTED BY MOLECULAR MARKERS HEMOSTASIS, Blood, 88(10), 1996, pp. 3069-3069
INTERMITTENT REGIONAL THERAPY WITH RT-PA IS NOT SUPERIOR TO SYSTEMIC THROMBOLYSIS IN DEEP-VEIN THROMBOSIS (DVT) - A GERMAN MULTICENTER TRIAL
Authors: SCHWIEDER G GRIMM W SIEMENS HJ FLOR B HILDEN A GMELIN E FRIEDRICH HJ WAGNER T
Citation: G. Schwieder et al., INTERMITTENT REGIONAL THERAPY WITH RT-PA IS NOT SUPERIOR TO SYSTEMIC THROMBOLYSIS IN DEEP-VEIN THROMBOSIS (DVT) - A GERMAN MULTICENTER TRIAL, Thrombosis and haemostasis, 74(5), 1995, pp. 1240-1243
ELEVATED PLASMA-LEVELS OF HEMOSTATIC MARKERS INDICATE A PRETHROMBOTICSTATE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION
Authors: MITUSCH R GARBE M SIEMENS HJ WAGNER T SHEIKHZADEH A DIEDERICH KW
Citation: R. Mitusch et al., ELEVATED PLASMA-LEVELS OF HEMOSTATIC MARKERS INDICATE A PRETHROMBOTICSTATE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION, Journal of the American College of Cardiology, 1994, pp. 10000442-10000442
THROMBOPHILIA - CHANGING LEVELS OF DIFFERENT PARAMETERS IN THE PERIOPERATIVE PHASE
Authors: SIEMENS HJ BRUECKNER S HAGELBERG S WAGNER T
Citation: Hj. Siemens et al., THROMBOPHILIA - CHANGING LEVELS OF DIFFERENT PARAMETERS IN THE PERIOPERATIVE PHASE, Thrombosis and haemostasis, 69(6), 1993, pp. 1358-1358
COAGULATORY DIFFERENCES IN DIALYSIS PATIENTS WITH AND WITHOUT SHUNT PROBLEMS
Authors: SIEMENS HJ FAERBER P WINTERHOFF R SCHULZ E BRUECKNER S WAGNER T SACK K
Citation: Hj. Siemens et al., COAGULATORY DIFFERENCES IN DIALYSIS PATIENTS WITH AND WITHOUT SHUNT PROBLEMS, Thrombosis and haemostasis, 69(6), 1993, pp. 1358-1358
EFFECTS OF TEMPERATURE ON THE THERAPEUTIC EFFICACY AND PHARMACOKINETICS OF IFOSFAMIDE
Authors: WIEDEMANN GJ SIEMENS HJ MENTZEL M BIERSACK A WOSSMANN W KNOCKS D WEISS C WAGNER T
Citation: Gj. Wiedemann et al., EFFECTS OF TEMPERATURE ON THE THERAPEUTIC EFFICACY AND PHARMACOKINETICS OF IFOSFAMIDE, Cancer research, 53(18), 1993, pp. 4268-4272
Risultati: 1-19 |